Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson's Disease
Journal of Movement Disorders
; : 69-79, 2017.
Article
en En
| WPRIM
| ID: wpr-38089
Biblioteca responsable:
WPRO
ABSTRACT
Parkinson's disease (PD), the second most common neurodegenerative disorder after Alzheimer's disease, is characterized by the loss of nigral dopaminergic neurons. PD leads to a series of clinical symptoms, including motor and non-motor disturbances. α-synuclein, the major component of Lewy bodies, is a hallmark lesion in PD. In this review, we concentrate on presenting the latest research on the structure, distribution, and function of α-synuclein, and its interactions with PD. We also summarize the clinic applications of α-synuclein, which suggest its use as a biomarker, and the latest progress in α-synuclein therapy.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Enfermedad de Parkinson
/
Cuerpos de Lewy
/
Enfermedades Neurodegenerativas
/
Alfa-Sinucleína
/
Neuronas Dopaminérgicas
/
Enfermedad de Alzheimer
Idioma:
En
Revista:
Journal of Movement Disorders
Año:
2017
Tipo del documento:
Article